Breast cancer-related lymphedema: Comparing direct costs of a prospective surveillance model and a traditional model of care

Physical Therapy

Volumn 92, Issue 1, 2012, Pages 152-163

  Stout, Nicole L ^a   Pfalzer, Lucinda A ^b   Springer, Barbara ^c   Levy, Ellen ^d   McGarvey, Charles L ^e   Danoff, Jerome V ^f   Gerber, Lynn H ^g   Soballe, Peter W ^h  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN FLINT   (United States)

^c Virginia Office of the Surgeon General   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e CLM Consulting   (United States)

^f GEORGE WASHINGTON UNIVERSITY   (United States)

^g GEORGE MASON UNIVERSITY   (United States)

^h NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST TUMOR; DISEASE COURSE; ECONOMICS; FEMALE; HEALTH SURVEY; HUMAN; LYMPHEDEMA; PHYSIOTHERAPY; PROSPECTIVE STUDY; SECONDARY PREVENTION;

BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHEDEMA; PHYSICAL THERAPY MODALITIES; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SECONDARY PREVENTION;

EID: 84855251997     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20100167     Document Type: Article

References (83)

1. Kita K, Hujino K, Nasu T, et al. A simple protocol for preventing falls and fractures in elderly individuals with musculoskeletal disease. Osteoporos Int. 2007;18:611-619.
2. Tosi LL, Maher N, Moore DW, et al. Adults with cerebral palsy: a workshop to define the challenges of treating and preventing secondary musculoskeletal and neuromuscular complications in this rapidly growing population. Dev Med Child Neurol. 2009;51(suppl 4):2-11.
3. Levey AS, Schoolwerth AC, Burrows NR, et al. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53:522-535.
4. Karmisholt K, Gotzsche PC. Physical activity for secondary prevention of disease: systematic reviews of randomised clinical trials. Dan Med Bull. 2005;52:90-94.
5. Newton RU, Galvao DA. Exercise in prevention and management of cancer. Curr Treat Options Oncol. 2008;9:135-146.
6. Dooley WC. Reducing surgical morbidity by pre-emptive management. J Surg Res. 2009;157: 154.
7. Wallace R. Public Health and Preventive Medicine. 15th ed. New York, NY: McGraw Hill; 2007.
8. Stout NL. Cancer prevention in physical therapist practice. Phys Ther. 2009;89: 1119-1122.
9. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005;19:871-881.
10. Katula JA, Vitolins MZ, Rosenberger EL, et al. Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods. Contemp Clin Trials. 2010;31: 71-81.
11. Ades PA. Individualized preventive care in cardiac rehabilitation: adapted from AACVPR Award of Excellence Lecture, Charleston, WVa, October, 2006. J Cardiopulm Rehabil Prev. 2007;27:130-134.
12. Fialka-Moser V, Crevenna R, Korpan M, Quittan M. Cancer rehabilitation: particularly with aspects on physical impairments. J Rehabil Med. 2003;35:153-162.
13. Cheville AL, Tchou J. Barriers to rehabilitation following surgery for primary breast cancer. J Surg Oncol. 2007;95:409-418.
14. Schmitz KH, Cappola AR, Stricker CT, et al. The intersection of cancer and aging: establishing the need for breast cancer rehabilitation. Cancer Epidemiol Biomarkers Prev. 2007;16:866-872.
15. Devoogdt N, Vank M, Christiaens MR, et al. Short-and long-term recovery of upper limb function after axillary lymph node dissection. Eur J Cancer Care (Engl). 2011;20:77-86.
16. Nesvold IL, Dahl AA, Lokkevik E, et al. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008; 47:835-842.
17. Karki A, Simonen R, Malkia E, Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med. 2005;37:180-188.
18. Rietman JS, Dijkstra PU, Debreczeni R, et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004;26: 78-84.
19. Engel J, Kerr J, Schlesinger-Raab A, et al. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients [erratum in: Breast Cancer Res Treat. 2003;80:233]. Breast Cancer Res Treat. 2003;79:47-57.
20. Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759-767.
21. Sagen A, Karesen R, Sandvik L, Risberg MA. Changes in arm morbidities and health-related quality of life after breast cancer surgery: a five-year follow-up study. Acta Oncol. 2009;48:1111-1118.
22. Cinar N, Seckin U, Keskin D, et al. The effectiveness of early rehabilitation in patients with modified radical mastectomy. Cancer Nurs. 2008;31:160-165.
23. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer. 1998;83(12 suppl American):2776-2781.
24. Deutsch M, Land S, Begovic M, Sharif S. The incidence of arm edema in women with breast cancer randomized on the national surgical adjuvant breast and bowel project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 2008; 70:1020-1024.
25. Morrell RM, Halyard MY, Schild SE, et al. Breast cancer-related lymphedema. Mayo Clin Proc. 2005;80:1480-1484.
26. Thomas-Maclean RL, Hack T, Kwan W, et al. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008;35:65-71.
27. Stanton AW, Modi S, Mellor RH, et al. Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol. 2009;7:29-45.
28. Golshan M, Smith B. Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol. 2006;4:381-386.
29. Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: an underestimated health problem. QJM. 2003;96:731-738.
30. Armer J, Fu MR, Wainstock JM, et al. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37:73-91.
31. Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27:2007-2014.
32. Stout Gergich NL, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112:2809-2819.
33. Boccardo FM, Ansaldi F, Bellini C, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer [erratum in: Lymphology. 2009;42:149]. Lymphology. 2009; 42:1-9.
34. Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat. 2002;75: 51-64.
35. Lauridsen MC, Christiansen P, Hessov I. The effect of physiotherapy on shoulder function in patients surgically treated for breast cancer: a randomized study. Acta Oncol. 2005;44:449-457.
36. Bland KL, Perczyk R, Du W, et al. Can a practicing surgeon detect early lymphedema reliably? Am J Surg. 2003; 186:509-513.
37. Thorpe KE, Howard DH. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. Health Aff (Millwood). 2006;25:w378-w388.
38. Karki A, Anttila H, Tasmuth T, Rautakorpi UM. Lymphoedema therapy in breast cancer patients: a systematic review on effectiveness and a survey of current practices and costs in Finland. Acta Oncol. 2009;48: 850-859.
39. Lipscomb J, Yabroff KR, Brown ML, et al. Health care costing: data, methods, current applications. Med Care. 2009;47(7 suppl 1):S1-S6.
40. Fishman PA, Hornbrook MC. Assigning resources to health care use for health services research: options and consequences. Med Care. 2009;47(7 suppl 1):S70-S75.
41. Hayes SC, Janda M, Cornish B, et al. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008;26: 3536-3542.
42. Ronka R, von Smitten K, Tasmuth T, Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast. 2005;14:28-36.
43. Stout Gergich NL, Pfalzer LA, McGarvey C, et al. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008; 112:2809-2819.
44. Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396.
45. The International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2009 concensus document of the International Society of Lymphology. Lymphology. 2009;42:51-60.
46. Cheville AL, McGarvey CL, Petrek JA, et al. The grading of lymphedema in oncology clinical trials. Semin Radiat Oncol. 2003; 13:214-225.
47. Todd J, Scally A, Dodwell D, et al. A randomised controlled trial of two programmes of shoulder exercise following axillary node dissection for invasive breast cancer. Physiotherapy. 2008;94:265-273.
48. Ko DS, Lerner R, Klose G, Cosimi AB. Effective treatment of lymphedema of the extremities. Arch Surg. 1998;133:452-458.
49. Foldi E, Foldi M, Clodius L. The lymphedema chaos: a lancet. Ann Plast Surg. 1989;22:505-515.
50. Casley-Smith JR, Boris M, Weindorf S, Lasinski B. Treatment for lymphedema of the arm; the Casley-Smith method: a noninvasive method produces continued reduction. Cancer. 1998;83(12 suppl American):2843-2860.
51. Boris M, Weindorf S, Lasinski B, Boris G. Lymphedema reduction by noninvasive complex lymphedema therapy. Oncology (Williston Park). 1994;8:95-106.
52. Badger C, Preston N, Seers K, Mortimer P. Physical therapies for reducing and controlling lymphoedema of the limbs. Cochrane Database Syst Rev. 2004(4): CD003141.
53. Linnitt N, Davies R. Fundamentals of compression in the management of lymphoedema. Br J Nurs. 2007;16:588, 590, 592.
54. Bar Ad V, Cheville A, Solin LJ, et al. Time course of mild arm lymphedema after breast conservation treatment for earlystage breast cancer. Int J Radiat Oncol Biol Phys. 2010;76:85-90.
55. Casley-Smith JR. Alterations of untreated lymphedema and it's grades over time. Lymphology. 1995;28:174-185.
56. Bland KL, Perczyk R, Du W, et al. Can a practicing surgeon detect early lymphedema reliably? Am J Surg. 2003;186: 509-513.
57. Centers for Medicare and Medicaid Services. Physician fee schedule. Available at: http://www.cms.gov/pfslookup/02_PFS search.asp?agree_yes&next_Accept. Accessed November 14, 2009.
58. American Medical Association. Current Procedural Terminology codes. Available at: http://www.ama-assn.org/ama/pub/ physician-resources/solutions-managingyour-practice/coding-billing-insurance/ cpt.shtml. Accessed May 1, 2010.
59. Hampton S. Elvarex compression garments in the management of lymphoedema. Br J Nurs. 2003;12:925-929.
60. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004;10:405-411.
61. Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM. Shoulder movement after breast cancer surgery: results of a randomised controlled study of postoperative physiotherapy. Breast Cancer Res Treat. 2002;75:35-50.
62. Springer BA, Levy E, McGarvey C, et al. Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer. Breast Cancer Res Treat. 2010;120:135-147.
63. Gordon LG, Scuffham P, Battistutta D, et al. A cost-effectiveness analysis of two rehabilitation support services for women with breast cancer. Breast Cancer Res Treat. 2005;94:123-133.
64. Gordon L, Scuffham P, Hayes S, Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology. 2007; 16:1130-1139.
65. Chirikos TN, Russell-Jacobs A, Jacobsen PB. Functional impairment and the economic consequences of female breast cancer. Women Health. 2002;36:1-20.
66. Marshall DA, Hux M. Design and analysis issues for economic analysis alongside clinical trials. Med Care. 2009;47(7 suppl 1):S14-S20.
67. Gold MR, Russell LB, Weinstein MC. Cost Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:176-209.
68. Hoerger TJ. Using costs in costeffectiveness models for chronic diseases: lessons from diabetes. Med Care. 2009; 47(7 suppl 1):S21-S27.
69. Woo PC, Lum PN, Wong SS, et al. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis. 2000;19:294-297.
70. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98:343-348.
71. American Cancer Society. Breast Cancer Facts and Figures 2008. Available at: http:// www.cancer.org/downloads/. Accessed December 15, 2008.
72. Paskett ED, Naughton MJ, McCoy TP, et al. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007;16:775-782.
73. Peterson LE, Goodman C, Karnes EK, et al. Assessment of the quality of cost analysis literature in physical therapy. Phys Ther. 2009;89:733-755.
74. Orr RK, Col NF, Kuntz KM. A costeffectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes. Surgery. 1999;126:568-576.
75. Cheville AL, Almoza M, Courmier JN, Basford JR. A prospective cohort study defining utilities using time trade-offs and the Euroqol-5D to assess the impact of cancerrelated lymphedema. Cancer. 2010;116: 3722-3731.
76. Soran A, D'Angelo G, Begovic M, et al. Breast cancer-related lymphedema: what are the significant predictors and how they affect the severity of lymphedema? Breast J. 2006;12:536-543.
77. Karnon J. Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation. Health Econ. 2003;12:837-848.
78. Karnon J, Brown J. Selecting a decision model for economic evaluation: a case study and review. Health Care Manag Sci. 1998;1:133-140.
79. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-338.
80. Drouin JS, Young TJ, Beeler J, et al. Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer. Cancer. 2006;107:2490-2495.
81. National Lymphedema Network. Position statement on screening and measurement for early detection of breast cancer-related lymphedema. 2011. Available at: http://www.lymphnet.org/pdfDocs/nln BCLE.pdf.
82. National Accreditation Program for Breast Centers. Breast Center Standards Manual.
83. Available at: http://www.accredited breastcenters.org/standards/2011standards manual.pdf.